AI Buyer Insights:

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Neuren Pharmaceuticals Data, Technology Stack, and Enterprise Applications
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2017 2017
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Content Management Content Management 2023 2023
Digital Signing Content Management 2025 2025
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Tag Management CRM 2022 2022
IT Decision Makers and Key Stakeholders at Neuren Pharmaceuticals
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Neuren Pharmaceuticals Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Neuren Pharmaceuticals Technographics

Neuren Pharmaceuticals is a Life Sciences organization based in Australia, with around 30 employees and annual revenues of $132.0 million.

Neuren Pharmaceuticals operates a diverse technology stack with applications such as Amazon EC2, reCAPTCHA and Microsoft 365, covering areas like Application Hosting and Computing Services, Application Security (AppSec) and Collaboration.

Neuren Pharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Amazon Web Services (AWS), Google and Microsoft.

Neuren Pharmaceuticals recently adopted applications including Amazon CloudFront in 2025, DocuSign eSignature in 2025 and Cloudflare CDN in 2024, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Neuren Pharmaceuticals’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Neuren Pharmaceuticals’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Neuren Pharmaceuticals technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.